[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100392419":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":34,"responsibleParty":55,"collaborators":18,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":18,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":18,"enrollmentInfo":67,"targetDuration":18,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":18,"overallStatus":37,"whyStopped":18,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"University of Cincinnati","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"CPM","EXPERIMENTAL","The experimental group will have a CPM applied in the PACU immediately post-op and it will be utilized while the patient is awake in bed for 2 hours on and 2 hours off, when not mobilizing with Physical Therapy (PT). The experimental group will also have traditional PT, including sessions 1 to 3 times a week.",[13],"Device: CPM",{"label":15,"type":16,"description":17,"interventionNames":18},"No CPM","NO_INTERVENTION","The control group will have typical care, including working with physical therapy 1 to 3 times a week.",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":18},"DEVICE","CPM-continuous passive motion device.",[9],[25],{"name":26,"affiliation":5,"role":27},"Henry C Sagi, MD","PRINCIPAL_INVESTIGATOR",[29],{"name":30,"role":31,"phone":32,"phoneExt":18,"email":33},"Kimberly A Hasselfeld, MS","CONTACT","513-558-1933","hasselky@uc.edu",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Univrsity of Cincinnati Medical Center","RECRUITING","Cincinnati","Ohio","45267","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-84.51439,39.12711,{"lat":47,"lon":46},[50,53],{"name":51,"role":31,"phone":52,"phoneExt":18,"email":33},"Kim Hasselfeld, MS","5137776213",{"name":54,"role":31,"phone":52,"phoneExt":18,"email":18},"Henry Sagi, MD",{"type":27,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"H. Claude Sagi, MD","Principal Investigator","100392419","continuous-passive-motion-following-fixation-of-pelvic-and-knee-fractures-100392419",false,"NCT04389749","Continuous Passive Motion Following Fixation of Pelvic and Knee Fractures","The Role of Continuous Passive Motion in Pain Control of Patients Undergoing Operative Management of Isolated Acetabular Fractures, Supracondylar Femur Fractures, or Tibial Plateau Fracture: A Comparative Study","Inclusion Criteria:\n\n* Age 18 or greater\n* Isolated acetabular fractures, supracondylar femur fractures, or tibial plateau fracture\n* Have undergone operative intervention for fracture\n\nExclusion Criteria:\n\n* Injury to either lower extremity that affects the patient's ability to weight bear\n* Under the age of 18\n* Pregnant\n* A prisoner","ALL","18 Years",{"count":68,"type":69},100,"ESTIMATED","INTERVENTIONAL",[72],"NA","The investigators will directly compare the visual analog scale scores and narcotic pain medication requirements in the patients who have continuous passive motion (CPM) versus those who do not during the course of the hospital admission following an open reduction internal fixation surgery for acetabular fracture, supracondylar femur fracture, or a tibial plateau fracture.",[75],"Fractures, Bone","2026-04-28",{"date":78,"type":79},"2026-05-04","ACTUAL",{"date":81,"type":79},"2020-10-06",{"date":83,"type":69},"2027-06",{"name":5,"class":6},1]